Jerash Holdings US Inc (JRSH)
Official siteCONSUMER CYCLICAL • APPAREL MANUFACTURING • NASDAQ
Market Cap: $92.71M
Last updated: Nov 17, 2026 at 11:04 AM ET
Jerash Holdings US Inc (JRSH) P/E Ratio & Valuation History
Jerash Holdings US (JRSH) trades at 15.2x trailing earnings and 0.5x sales. Its P/S of 0.5x is above its 5-year median of 0.3x. Its forward P/E is 6.5x. The median P/E across 4 similar companies is 18.1x.
Current Multiples
Its forward P/E is below its trailing P/E, which implies earnings per share about 133.8% higher over the next year. Its free cash flow yield is 4.8%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 15.2x |
| Forward P/E | 6.5x |
| Price to sales | 0.5x |
| Price to book | 1.4x |
| EV/EBITDA | 6.6x |
| Price to FCF | 20.9x |
| EV/FCF | 19.6x |
| PEG | N/A |
| FCF yield | 4.8% |
Historical Medians
Against its 10-year medians, its P/S is in line and its P/B is 55.6% above 0.9x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/S | 0.5x | 0.3x | 0.5x |
| P/B | 1.4x | 0.7x | 0.9x |
Valuation History
Over the 6 of the 8 year ends shown that have a P/E, its P/E ranged from 8.6x in 2021 to 24.4x in 2020.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $3.05 | 20.3x | 0.3x | 0.6x |
| 2024 | $3.42 | N/A | 0.3x | 0.7x |
| 2023 | $3.11 | N/A | 0.3x | 0.6x |
| 2022 | $3.89 | 11.4x | 0.3x | 0.7x |
| 2021 | $6.47 | 8.6x | 0.7x | 1.1x |
| 2020 | $5.85 | 24.4x | 0.7x | 1.2x |
| 2019 | $5.86 | 9.6x | 0.7x | 1.2x |
| 2018 | $6.10 | 18.5x | 0.8x | 1.2x |
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About JRSH
What is JRSH's forward P/E ratio?
Jerash Holdings US has a forward P/E ratio of 6.5x.
Is JRSH stock overvalued?
GNG's valuation label for JRSH is Fairly valued. Its P/E of 15.2x compares with a median of 18.1x across 4 similar companies.
What is JRSH's price to sales ratio?
Jerash Holdings US has a price to sales ratio of 0.5x.
JRSH pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors